This MSc at Maastricht University focuses on how cognitive and clinical neuroscience informs drug development and neurohealth. You study psychiatric disorders and neuroimaging while learning how evidence is translated into therapies and healthcare practice.
The Master's program in Cognitive and Clinical Neuroscience with a specialization in Drug Development and Neurohealth at Maastricht University delves into the intersection of neuroscience and healthcare. This rigorous course equips students with an understanding of how cognitive and clinical neuroscience informs the development of therapies for psychiatric disorders, underpinned by the latest neuroimaging techniques.
The curriculum integrates essential neuroscience training with practical clinical skills, emphasizing translational research and evidence-based practices in neuropsychiatry. Key topics include:
The program also features a research component aligned with the specialization, allowing students to develop and apply research skills to topics pertinent to clinical neuroscience and drug development.
While there are no specific GRE, GMAT, or GPA requirements for this program, applicants should ensure they meet the general requirements for admission, which include a recent passport photograph and a valid identification document such as a passport or EU/EEA identity card. Proficiency in English is essential, with accepted qualifications including:
Graduates of this program will be well-prepared for a variety of roles in the fields of neuroscience and mental health. Potential career paths include positions in research institutions, pharmaceutical companies, clinical settings, and governmental organizations focused on mental health. The interdisciplinary training equips students with the skills needed to contribute to advancements in drug development and improve neurohealth outcomes.
Shortlist scholarships and plan your application — free guidance from our advisors.